ORAMED PHARMACEUTICALS (ORMP) stock: insider trades, news & valuation
Net sellingShare price and insider trades
ORAMED PHARMACEUTICALS insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 2 sold $1.2M of ORMP stock on the open market.
Get emailed when insiders cluster-buy stocks like ORMP
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ORMP insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $226K | 2 |
| Q3 2026 | — | 0 | $942K | 2 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 ORAMED PHARMACEUTICALS INC. insiders reported open-market purchases totaling $0, while 2 insiders reported sales totaling $1.2M. 4 of 4 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 2SEC | Joshua HexterCOO | Sell Plan | 30,0001,328,130 held (−2%) | $4.51 | $135K | -4.0% | — |
| Oct 2SEC | Avraham GabayCFO | Sell Plan | 20,000861,076 held (−2%) | $4.51 | $90K | -4.0% | — |
| Jul 2SEC | Joshua HexterCOO | Sell Plan | 137,0001,023,384 held (−12%) | $4.46 | $611K | -2.9% | — |
| Jul 2SEC | Avraham GabayCFO | Sell Plan | 73,360671,785 held (−10%) | $4.51 | $331K | -4.0% | — |
Insiders at ORAMED PHARMACEUTICALS INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Joshua HexterCOO | — | $746K | Oct 2, 2026 | — |
| Avraham GabayCFO | — | $421K | Oct 2, 2026 | — |
ORMP stock: common questions
Are ORAMED PHARMACEUTICALS INC. insiders buying ORMP stock?
In the past 12 months, 0 insiders reported open-market purchases of ORMP worth $0.
Are ORAMED PHARMACEUTICALS INC. insiders selling ORMP stock?
2 insiders reported sales worth $1.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ORMP's 52-week range?
Over the past year ORMP has traded between $2.04 and $5.34. It last closed at $4.33 on Oct 9, 2026.